401 related articles for article (PubMed ID: 27050050)
1. Which PCDAI Version Best Reflects Intestinal Inflammation in Pediatric Crohn Disease?
Turner D; Levine A; Walters TD; Focht G; Otley A; López VN; Koletzko S; Baldassano R; Mack D; Hyams J; Griffiths AM
J Pediatr Gastroenterol Nutr; 2017 Feb; 64(2):254-260. PubMed ID: 27050050
[TBL] [Abstract][Full Text] [Related]
2. Predicting Endoscopic Crohn's Disease Activity Before and After Induction Therapy in Children: A Comprehensive Assessment of PCDAI, CRP, and Fecal Calprotectin.
Zubin G; Peter L
Inflamm Bowel Dis; 2015 Jun; 21(6):1386-91. PubMed ID: 25851564
[TBL] [Abstract][Full Text] [Related]
3. Mathematical weighting of the pediatric Crohn's disease activity index (PCDAI) and comparison with its other short versions.
Turner D; Griffiths AM; Walters TD; Seah T; Markowitz J; Pfefferkorn M; Keljo D; Waxman J; Otley A; LeLeiko NS; Mack D; Hyams J; Levine A
Inflamm Bowel Dis; 2012 Jan; 18(1):55-62. PubMed ID: 21351206
[TBL] [Abstract][Full Text] [Related]
4. Clinical disease activity and endoscopic severity correlate poorly in children newly diagnosed with Crohn's disease.
Carman N; Tomalty D; Church PC; Mack DR; Benchimol EI; Otley AR; Jacobson K; Huynh HQ; DeBruyn JC; El-Matary W; Sherlock M; Van Limbergen J; Griffiths AM; Walters TD;
Gastrointest Endosc; 2019 Feb; 89(2):364-372. PubMed ID: 30273592
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B
World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660
[TBL] [Abstract][Full Text] [Related]
6. Development and Validation of the Mucosal Inflammation Noninvasive Index For Pediatric Crohn's Disease.
Cozijnsen MA; Ben Shoham A; Kang B; Choe BH; Choe YH; Jongsma MME; Russell RK; Ruemmele FM; Escher JC; de Ridder L; Koletzko S; Martín-de-Carpi J; Hyams J; Walters T; Griffiths A; Turner D
Clin Gastroenterol Hepatol; 2020 Jan; 18(1):133-140.e1. PubMed ID: 30981008
[TBL] [Abstract][Full Text] [Related]
7. Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial.
Peyrin-Biroulet L; Reinisch W; Colombel JF; Mantzaris GJ; Kornbluth A; Diamond R; Rutgeerts P; Tang LK; Cornillie FJ; Sandborn WJ
Gut; 2014 Jan; 63(1):88-95. PubMed ID: 23974954
[TBL] [Abstract][Full Text] [Related]
8. Predictors of Long-term Clinical and Endoscopic Remission in Children With Crohn Disease Treated With Infliximab.
D'Arcangelo G; Oliva S; Dilillo A; Viola F; Civitelli F; Isoldi S; Cucchiara S; Aloi M
J Pediatr Gastroenterol Nutr; 2019 Jun; 68(6):841-846. PubMed ID: 30633110
[TBL] [Abstract][Full Text] [Related]
9. Early Mucosal Healing with Exclusive Enteral Nutrition is Associated with Improved Outcomes in Newly Diagnosed Children with Luminal Crohn's disease.
Grover Z; Burgess C; Muir R; Reilly C; Lewindon PJ
J Crohns Colitis; 2016 Oct; 10(10):1159-64. PubMed ID: 26980840
[TBL] [Abstract][Full Text] [Related]
10. Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC.
Ferrante M; Colombel JF; Sandborn WJ; Reinisch W; Mantzaris GJ; Kornbluth A; Rachmilewitz D; Lichtiger S; D'Haens GR; van der Woude CJ; Danese S; Diamond RH; Oortwijn AF; Tang KL; Miller M; Cornillie F; Rutgeerts PJ;
Gastroenterology; 2013 Nov; 145(5):978-986.e5. PubMed ID: 23954314
[TBL] [Abstract][Full Text] [Related]
11. Assessing pediatric ileocolonic Crohn's disease activity based on global MR enterography scores.
Pomerri F; Al Bunni F; Zuliani M; Guariso G; Gasparetto M; Giorgi B; Cananzi M; Muzzio PC
Eur Radiol; 2017 Mar; 27(3):1044-1051. PubMed ID: 27277259
[TBL] [Abstract][Full Text] [Related]
12. Role of fecal calprotectin testing to predict relapse in teenagers with inflammatory bowel disease who report full disease control.
van Rheenen PF
Inflamm Bowel Dis; 2012 Nov; 18(11):2018-25. PubMed ID: 22275341
[TBL] [Abstract][Full Text] [Related]
13. Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI.
Schoepfer AM; Beglinger C; Straumann A; Trummler M; Vavricka SR; Bruegger LE; Seibold F
Am J Gastroenterol; 2010 Jan; 105(1):162-9. PubMed ID: 19755969
[TBL] [Abstract][Full Text] [Related]
14. Serum ficolin-2 correlates worse than fecal calprotectin and CRP with endoscopic Crohn's disease activity.
Schaffer T; Schoepfer AM; Seibold F;
J Crohns Colitis; 2014 Sep; 8(9):1125-32. PubMed ID: 24636141
[TBL] [Abstract][Full Text] [Related]
15. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
[TBL] [Abstract][Full Text] [Related]
16. Correlations of plasma citrulline levels with clinical and endoscopic score and blood markers according to small bowel involvement in pediatric Crohn disease.
Lee EH; Ko JS; Seo JK
J Pediatr Gastroenterol Nutr; 2013 Nov; 57(5):570-5. PubMed ID: 23752073
[TBL] [Abstract][Full Text] [Related]
17. Impact of disease location on fecal calprotectin levels in Crohn's disease.
Gecse KB; Brandse JF; van Wilpe S; Löwenberg M; Ponsioen C; van den Brink G; D'Haens G
Scand J Gastroenterol; 2015 Jul; 50(7):841-7. PubMed ID: 25636819
[TBL] [Abstract][Full Text] [Related]
18. The diagnostic usefulness of fecal lactoferrin in the assessment of Crohn's disease activity.
Klimczak K; Lykowska-Szuber L; Eder P; Krela-Kazmierczak I; Stawczyk-Eder K; Szymczak A; Michalak M; Studniarek A; Linke K
Eur J Intern Med; 2015 Oct; 26(8):623-7. PubMed ID: 26198785
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn's disease.
Ordás I; Rimola J; Rodríguez S; Paredes JM; Martínez-Pérez MJ; Blanc E; Arévalo JA; Aduna M; Andreu M; Radosevic A; Ramírez-Morros AM; Pinó S; Gallego M; Jauregui-Amezaga A; Ricart E; Panés J
Gastroenterology; 2014 Feb; 146(2):374-82.e1. PubMed ID: 24177375
[TBL] [Abstract][Full Text] [Related]
20. A new rapid test for fecal calprotectin predicts endoscopic remission and postoperative recurrence in Crohn's disease.
Lobatón T; López-García A; Rodríguez-Moranta F; Ruiz A; Rodríguez L; Guardiola J
J Crohns Colitis; 2013 Dec; 7(12):e641-51. PubMed ID: 23810085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
